Franklin Resources Inc Novartis Ag Transaction History

Franklin Resources Inc

$304 Billion
Q1 2024

A detailed history of Franklin Resources Inc transactions in Novartis Ag stock. As of the latest transaction made, Franklin Resources Inc holds 5,699,789 shares of NVS stock, worth $588 Million. This represents 0.18% of its overall portfolio holdings.

Number of Shares

5,699,789

Previous 5,914,989 3.64%

Holding current value

$588 Million

Previous $597 Million 7.68%

% of portfolio

0.18%

Previous 0.29%

27 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$95.27 - $108.47 $20.5 Million - $23.3 Million	-215,200 Reduced 3.64%	5,699,789 $551 Million
Q4 2023 Feb 09, 2024	SELL	$92.27 - $101.54 $27.3 Million - $30.1 Million	-296,103 Reduced 4.77%	5,914,989 $597 Million
Q3 2023 Nov 13, 2023	BUY	$94.73 - $105.13 $2.61 Million - $2.9 Million	27,546 Added 0.45%	6,211,092 $633 Million
Q2 2023 Aug 11, 2023	SELL	$92.52 - $104.91 $73.9 Million - $83.8 Million	-798,746 Reduced 11.44%	6,183,546 $624 Million
Q1 2023 May 12, 2023	BUY	$80.03 - $92.81 $22.4 Million - $26 Million	279,999 Added 4.18%	6,982,292 $642 Million

Q4 2022 Feb 10, 2023	SELL	$75.55 - $92.52 $37.6 Million - $46 Million	-497,386 Reduced 6.91%	6,702,293 $608 Million
Q3 2022 Nov 14, 2022	SELL	$74.61 - $87.26 $21.5 Million - $25.2 Million	-288,495 Reduced 3.85%	7,199,679 $547 Million
Q2 2022 Aug 11, 2022	BUY	$80.52 - $93.75 $20.8 Million - $24.3 Million	258,830 Added 3.58%	7,488,174 $633 Million
Q1 2022 May 13, 2022	SELL	$80.11 - $90.62 $153 Million - $173 Million	-1,911,463 Reduced 20.91%	7,229,344 $634 Million
Q4 2021 Feb 11, 2022	BUY	$79.7 - $88.13 $188 Million - $208 Million	2,361,944 Added 34.84%	9,140,807 $800 Million
Q3 2021 Nov 12, 2021	SELL	$81.78 - $95.14 $60.8 Million - $70.7 Million	-743,343 Reduced 9.88%	6,778,863 $554 Million
Q2 2021 Aug 13, 2021	SELL	$85.24 - $94.15 $78.6 Million - $86.8 Million	-922,205 Reduced 10.92%	7,522,206 $686 Million
Q1 2021 May 13, 2021	SELL	$83.5 - $98.47 $6.31 Million - $7.45 Million	-75,611 Reduced 0.89%	8,444,411 $722 Million
Q4 2020 Feb 10, 2021	BUY	$78.07 - $94.43 $14.8 Million - $17.9 Million	189,509 Added 2.27%	8,520,022 $805 Million
Q3 2020 Nov 12, 2020	SELL	$82.14 - $91.0 $12.7 Million - $14.1 Million	-154,790 Reduced 1.82%	8,330,513 $724 Million
Q2 2020 Aug 13, 2020	SELL	$80.93 - $91.1 $32.3 Million - $36.3 Million	-398,937 Reduced 4.49%	8,485,303 $734 Million
Q1 2020 May 13, 2020	SELL	$70.67 - $99.01 $206 Million - $289 Million	-2,914,944 Reduced 24.7%	8,884,240 $733 Million
Q4 2019 Feb 12, 2020	SELL	$84.35 - $95.37 $45.1 Million - $51 Million	-534,300 Reduced 4.33%	11,799,184 $1.12 Billion
Q3 2019 Nov 14, 2019	SELL	$85.54 - $94.26 $135 Million - $148 Million	-1,575,161 Reduced 11.33%	12,333,484 $1.07 Billion
Q2 2019 Aug 14, 2019	SELL	$75.4 - $92.8 $23.2 Million - $28.5 Million	-307,489 Reduced 2.16%	13,908,645 $1.27 Billion
Q1 2019 May 14, 2019	SELL	$75.32 - $86.15 $869,945 - $995,032	-11,550 Reduced 0.08%	14,216,134 $1.37 Billion
Q4 2018 Feb 12, 2019	SELL	$73.66 - $82.02 $67.6 Million - $75.2 Million	-917,341 Reduced 6.06%	14,227,684 $1.22 Billion
Q3 2018 Nov 13, 2018	SELL	$66.94 - $77.43 $43.5 Million - $50.4 Million	-650,568 Reduced 4.12%	15,145,025 $1.3 Billion
Q2 2018 Aug 14, 2018	BUY	$64.91 - $73.36 $64.6 Million - $73 Million	994,495 Added 6.72%	15,795,593 $1.19 Billion
Q1 2018 May 10, 2018	SELL	$70.39 - $84.15 $2.9 Million - $3.47 Million	-41,236 Reduced 0.28%	14,801,098 $1.2 Billion
Q4 2017 Feb 14, 2018	SELL	$72.33 - $77.64 $50.1 Million - $53.7 Million	-692,263 Reduced 4.46%	14,842,334 $1.25 Billion
Q3 2017 Nov 13, 2017	BUY	$74.14 - $77.27 $1.15 Billion - $1.2 Billion	15,534,597	15,534,597 $1.33 Billion

Others Institutions Holding NVS

# of Institutions

1,342

Shares Held

140M

Call Options Held

1.15M

Put Options Held

866K

View Full List

About NOVARTIS AG

Ticker NVS
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,151,000,064
Market Cap $222B
Description
Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...

More about NVS

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Franklin Resources Inc, based on Form 13F filings with the SEC.

News

Stay updated on Franklin Resources Inc with notifications on news.

Account

Franklin Resources Inc Novartis Ag Transaction History